GB
Great Bay Bio at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Great Bay Bio brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program presents antibodies from its AlfaBodY platform, including GIPR antagonist antibodies that sustain weight loss in obese mice. A poster shows an ActRIIA/B antibody given with semaglutide enhancing fat loss and lean mass.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
GB Great Bay Bio Hong Kong | |
Biotech whose AlfaBodY antibody platform yields obesity candidates, including GIPR antagonist and activin receptor antibodies. | Talk Sat Nov 14 4:45pm–5:00pm Poster Sun Nov 15 2:30pm–3:30pm AlfaBodY-Derived ActRIIA/B Antibody With Semaglutide Enhances Fat Loss and Lean Mass in DIO Mice Metabolism and integrative physiology |
Find decision makers at Great Bay Bio
Tell us what you sell and we’ll find the people at Great Bay Bio most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction